Over the past three decades, the global prevalence of diabetes has risen to record levels. There has been a corresponding increase in the use of the glycated hemoglobin A1c (HbA1c) test to assess or detect diabetes. An increasing number of underwriters are now also considering using HbA1c as a good blood biomarker for mortality.
Over the last several years, we have seen rapid advances in the technologies that aim to treat people with diabetes.
As today’s medical and technological advances continue to be utilized and applied to Diabetes mellitus (DM), a newer and even more complex framework for the disease is emerging, which may help us further our understanding of it. RGA's Dr. Karneen Tam explores the most recent classification update and some of the newer thinking emerging about DM in Reinsurance News.
Two significant and parallel change factors – innovative new medicines and advances in digital technologies – are shifting diabetes management into a new and more positive era, significantly improving the prognosis and quality of life for diabetics, and paving the way for new Life underwriting and product opportunities.
Dr. Karneen Tam, Medical Consultant, RGA Asia Pacific, provides an in-depth discussion on cardiovascular and kidney complications related to diabetes mellitus and the mitigating effects of newer classes of medication in ReFlections.
Our recent conversations with insurance partners highlight six prevalent risks at the top of mind for industry leaders today.
Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes, according to a study published online Aug. 4 in Diabetes Care.
This video presents findings from a recent study on diabetes conducted by the MIB Mortality Risk Analysis Committee.
The link to the study is here: http://www.mibgroup.com/pdf/2016_06_diabetes_study.pdf
Patients with impaired glucose tolerance (IGT) face an increased risk of mortality, with much of the increased risk of mortality associated with progression to type 2 diabetes, according to a study published online July 13 in Diabetes Care.
Patients with diabetes are much more likely to die after an acute myocardial infarction (AMI) than patients without diabetes, according to a study published online June 15 in the Journal of Epidemiology and Community Health.